Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:

NCT ID: NCT04226963 Completed - Clinical trials for Major Depressive Disorder

A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders

GDKet
Start date: December 4, 2019
Phase:
Study type: Observational [Patient Registry]

This study aims to openly test the long-term safety, tolerability and effectiveness of repeated administration of IV, nasal spray and oral ketamine for treatment-resistant mood disorders.

NCT ID: NCT04226742 Completed - Depression, Anxiety Clinical Trials

Evaluation of a Crowd-Powered Web Platform for Depression and Anxiety

Start date: February 18, 2021
Phase: N/A
Study type: Interventional

100 participants will be enrolled in a two-armed randomized controlled trial of the Accumulated Depression and Anxiety Plans and Treatments (ADAPT) platform which integrates internet Cognitive Behavioral Therapy (iCBT) to determine impact on symptoms of depression and anxiety. This trial will pilot the effectiveness of the ADAPT platform, and evaluate the extent to which the ADAPT platform engages putative targets of personal relevance, skills use, and skills mastery.

NCT ID: NCT04225169 Completed - Breathing Exercises Clinical Trials

The Effect of Diaphragmatic Breathing Exercise on Pain, Anxiety, and Depression

Start date: May 23, 2019
Phase: N/A
Study type: Interventional

Background: After total knee replacement (TKR) surgery, patients often experience intense levels of pain, stress, and anxiety that can adversely affect postoperative recovery. Diaphragmatic breathing exercise (DBE) may help patients manage pain and emotional distress. Aim: The aim of this study was to investigate the effect of DBE on pain, anxiety, and depression in patients undergoing TKR. Methods: The study population consisted of patients who underwent TKR surgery in the orthopedic ward of Çankırı State Hospital between May and August 2019. The study sample included a total of 38 patients satisfying the inclusion criteria. Stratified randomization was used to assign the patients into sex-matched intervention group (n=19) and control group (n=19). Patients in the intervention group were also trained in the DBE procedure. Pain scores were evaluated at 1, 2, 4, 8, 12, and 24 hours postoperatively, while the anxiety and depression was applied on the postoperative day 2. Data were analyzed using descriptive statistics, Chi-square test, and Mann-Whitney U test.

NCT ID: NCT04221230 Completed - Clinical trials for Major Depressive Disorder

Study in Major Depressive Disorder With BTRX-335140 (NMRA-335140) vs Placebo

Start date: December 14, 2019
Phase: Phase 2
Study type: Interventional

A proof of concept (POC) study evaluating the impact of BTRX-335140 (NMRA-335140) relative to placebo on symptoms of major depressive disorder (MDD) in adult participants with MDD and symptoms of anhedonia and anxiety following 8 weeks of double-blind treatment as assessed by the HAMD-17 Scale.

NCT ID: NCT04218214 Completed - Depression Clinical Trials

Mixed Methods Implementation Evaluation of an Integrated Depression and Microfinance Program for Women in Vietnam

LIFE-DM
Start date: December 7, 2017
Phase:
Study type: Observational [Patient Registry]

This is an implementation project to develop a model to support implementation of LIFE-DM, an evidence-based practice (EBP) program that integrates depression management with microfinance services to address both poverty and depression among low-income women in Vietnam. This evaluation is a mixed methods study that will 1) describe the development of community-partnered implementation process, 2) study the effectiveness of the training and implementation support plan on provider and patient outcomes, and 3) identify factors that impact implementation success.

NCT ID: NCT04216095 Completed - Clinical trials for Major Depressive Disorder

Comparative Effectiveness Clinical Trial of MST Compared to ECT in Major Depressive Disorder

Start date: June 7, 2013
Phase: Phase 2/Phase 3
Study type: Interventional

This study was a prospective, open-label comparative effectiveness clinical trial, comparing magnetic seizure therapy (MST) to ECT in patients with Major Depressive Disorder (MDD).

NCT ID: NCT04214600 Completed - Depression Clinical Trials

Cognitive Behavioral Therapy for Adherence in Patients With Type 2 Diabetes

Start date: April 30, 2019
Phase: N/A
Study type: Interventional

Despite the significant relationship between depression and diabetes, there are few published studies testing the effect of cognitive behavioral therapy in improving disease outcomes among diabetics in primary healthcare settings in Egypt. The study aims at assessing the efficacy of cognitive behavioral therapy combined with diabetes education versus control receiving diabetes education alone in helping patients with Type 2 Diabetes and depressive symptoms to achieve glycemic control and compliance to treatment.

NCT ID: NCT04211285 Completed - Depression Clinical Trials

e-GAB: Electronic Geriatric Assessment Bundle: Development of an Arabic Self-administered Android CGA Application

Start date: August 1, 2018
Phase:
Study type: Observational

The aim of this study is to design and assess the accuracy of administering the electronic Geriatric Assessment Bundle (e-GAB) compared to geriatrician performed comprehensive geriatric assessment (CGA) in a group of Egyptian elderly. The development of an Arabic software platform for CGA can improve the clinical practice by providing a valid user friendly tool to collect and analyze data for geriatric patients attending non- Geriatric health care service.

NCT ID: NCT04210856 Completed - Depression Clinical Trials

Effects of Landscapes on the Brain

Start date: February 28, 2019
Phase: N/A
Study type: Interventional

There is an established consensus between researchers that the contact with natural environments has beneficial influence on mental health and well-being of people exposed to them. The knowledge in this area is based mostly on the correlational analyses, but more research is needed to explore the causal relationships between the human and his environment. More specifically, in order to identify specific restorative mechanisms in response to the specific types and components of the designed landscapes, especially in the highly urbanized context. This study will attempt to find the psychophysiological responses in human brain to landscapes videos (in the lab), and real landscapes with different visual quality, carefully pre-selected and analysed in terms of landscape composition. In the study the rigorous experimental protocol will be administered in order to acquire qualitative and quantitative data both self-reported and measured by neuroscience tools, in order to demonstrate the causal effect of landscape exposure on the brain activity patterns and mood of healthy and depressed individuals.

NCT ID: NCT04210804 Completed - Bipolar Depression Clinical Trials

A Prophylactic Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder

Start date: April 1, 2014
Phase: Phase 2
Study type: Interventional

This study is a 52 week double-blind placebo controlled study of omega-3 polyunsaturated fatty acids (PUFAs) in bipolar disorder (who have a history of 3 or more episodes) to ascertain if omega-3 PUFAs reduce the risk of further relapse for both / either depressive or (hypo)manic episodes. This is a single-centre, 52 week, double-blind, randomised comparison of omega-3 PUFA (1g EPA and 1g DHA) versus placebo as adjunctive treatment in individuals with bipolar disorder